Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 18;6(4):106.
doi: 10.3390/medicines6040106.

Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review

Affiliations
Review

Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review

Ana Y Simão et al. Medicines (Basel). .

Abstract

Ayahuasca is a psychoactive beverage prepared traditionally from a mixture of the leaves and stems of Psychotria viridis and Banisteriopsis caapi, respectively, being originally consumed by indigenous Amazonian tribes for ritual and medicinal purposes. Over the years, its use has spread to other populations as a means to personal growth and spiritual connection. Also, the recreational use of its isolated compounds has become prominent. The main compounds of this tea-like preparation are N,N-dimethyltryptamine (DMT), β-Carbolines, and harmala alkaloids, such as harmine, tetrahydroharmine, and harmaline. The latter are monoamine-oxidase inhibitors and are responsible for DMT psychoactive and hallucinogenic effects on the central nervous system. Although consumers defend its use, its metabolic effects and those on the central nervous system are not fully understood yet. The majority of studies regarding the effects of this beverage and of its individual compounds are based on in vivo experiments, clinical trials, and even surveys. This paper will not only address the toxicological aspects of the ayahuasca compounds but also perform a comprehensive and critical review on the analytical methods available for their determination in biological and non-biological specimens, with special focus on instrumental developments and sample preparation approaches.

Keywords: Ayahuasca, toxicity, analytical determination.

PubMed Disclaimer

Conflict of interest statement

The authors confirm that this article content has no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of N,N-dimethyltryptamine (DMT), tetrahydroharmine (THH), harmaline (HML), and harmine (HMN).

References

    1. Labate B.C., Feeney K. Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. Int. J. Drug Policy. 2012;23:154–161. doi: 10.1016/j.drugpo.2011.06.006. - DOI - PubMed
    1. Andrade T.S., de Oliveira R., da Silva M.L., Von Zuben M.V., Grisolia C.K., Domingues I., Caldas E.D., Pic-Taylor A. Exposure to ayahuasca induces developmental and behavioral alterations on early life stages of zebrafish. Chem. Biol. Interact. 2018;293:133–140. doi: 10.1016/j.cbi.2018.08.001. - DOI - PubMed
    1. Gaujac A., Dempster N., Navickiene S., Brandt S.D., Andrade J.B. de Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry. Talanta. 2013;106:394–398. doi: 10.1016/j.talanta.2013.01.017. - DOI - PubMed
    1. McKenna D.J. Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacol. Ther. 2004;102:111–129. doi: 10.1016/j.pharmthera.2004.03.002. - DOI - PubMed
    1. Callaway J.C., McKenna D.J., Grob C.S., Brito G.S., Raymon L.P., Poland R.E., Andrade E.N., Andrade E.O., Mash D.C. Pharmacokinetics of Hoasca alkaloids in healthy humans. J. Ethnopharmacol. 1999;65:243–256. doi: 10.1016/S0378-8741(98)00168-8. - DOI - PubMed

LinkOut - more resources